Addex Therapeutics (ADXN) Net Margin (2022 - 2025)
Historic Net Margin for Addex Therapeutics (ADXN) over the last 4 years, with Q2 2025 value amounting to 2020.37%.
- Addex Therapeutics' Net Margin fell 144859300.0% to 2020.37% in Q2 2025 from the same period last year, while for Sep 2025 it was 9503.42%, marking a year-over-year decrease of 99451200.0%. This contributed to the annual value of 1746.04% for FY2024, which is 24005100.0% up from last year.
- Per Addex Therapeutics' latest filing, its Net Margin stood at 2020.37% for Q2 2025, which was down 144859300.0% from 1632.8% recorded in Q1 2025.
- Addex Therapeutics' Net Margin's 5-year high stood at 12465.56% during Q2 2024, with a 5-year trough of 642765.58% in Q4 2024.
- Moreover, its 4-year median value for Net Margin was 1005.32% (2022), whereas its average is 46388.93%.
- Examining YoY changes over the last 5 years, Addex Therapeutics' Net Margin showed a top increase of 128069500bps in 2024 and a maximum decrease of 2000000000bps in 2024.
- Over the past 4 years, Addex Therapeutics' Net Margin (Quarter) stood at 242.33% in 2022, then crashed by -2574bps to 5996.05% in 2023, then tumbled by -10620bps to 642765.58% in 2024, then soared by 100bps to 2020.37% in 2025.
- Its last three reported values are 2020.37% in Q2 2025, 1632.8% for Q1 2025, and 642765.58% during Q4 2024.